Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.062 AUD | 0.00% | 0.00% | -22.50% |
Apr. 17 | Shekel Brainweigh Appoints Chair/CEO | MT |
Mar. 27 | Shekel Brainweigh FY Loss Per Share Widens to $0.03, Revenue Grows 12% to $27.2 Million | MT |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 27.4 | 10.7 | 22.44 | 24.39 | 10.56 | 11.1 |
Enterprise Value (EV) 1 | 24.6 | 14.82 | 28.15 | 39.79 | 28.11 | 30.45 |
P/E ratio | -18.5 x | -3.14 x | -5.04 x | -3.43 x | -3.25 x | -1.9 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.47 x | 0.57 x | 1.23 x | 1.06 x | 0.4 x | 0.41 x |
EV / Revenue | 1.32 x | 0.79 x | 1.54 x | 1.72 x | 1.07 x | 1.12 x |
EV / EBITDA | -74.6 x | -7.53 x | -12 x | -11 x | -6.78 x | -8.25 x |
EV / FCF | -19 x | -5.82 x | 102 x | -10.5 x | -8.13 x | 21.3 x |
FCF Yield | -5.25% | -17.2% | 0.98% | -9.55% | -12.3% | 4.69% |
Price to Book | 2.3 x | 1.18 x | 4.64 x | 22.5 x | -35 x | -1.95 x |
Nbr of stocks (in thousands) | 139,000 | 139,000 | 139,000 | 160,000 | 192,644 | 203,286 |
Reference price 2 | 0.1971 | 0.0770 | 0.1615 | 0.1525 | 0.0548 | 0.0546 |
Announcement Date | 3/29/19 | 3/31/20 | 3/30/21 | 3/30/22 | 3/29/23 | 3/27/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 18.66 | 18.82 | 18.31 | 23.1 | 26.36 | 27.19 |
EBITDA 1 | -0.33 | -1.968 | -2.337 | -3.623 | -4.146 | -3.693 |
EBIT 1 | -0.52 | -2.161 | -3.255 | -3.877 | -4.422 | -3.938 |
Operating Margin | -2.79% | -11.48% | -17.78% | -16.78% | -16.78% | -14.48% |
Earnings before Tax (EBT) 1 | -1.224 | -3.079 | -4.449 | -6.615 | -2.666 | -5.461 |
Net income 1 | -1.205 | -3.41 | -4.453 | -6.767 | -3.06 | -5.712 |
Net margin | -6.46% | -18.12% | -24.33% | -29.29% | -11.61% | -21.01% |
EPS 2 | -0.0106 | -0.0245 | -0.0320 | -0.0444 | -0.0168 | -0.0288 |
Free Cash Flow 1 | -1.293 | -2.546 | 0.2772 | -3.8 | -3.457 | 1.427 |
FCF margin | -6.93% | -13.53% | 1.51% | -16.45% | -13.12% | 5.25% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/29/19 | 3/31/20 | 3/30/21 | 3/30/22 | 3/29/23 | 3/27/24 |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 10.42 | 7.941 | 10.36 | 10.62 | 12.48 | 13.12 | 13.24 | 13.39 |
EBITDA 1 | 0.517 | -1.424 | -0.188 | -1.608 | -0.459 | -1.554 | 1.217 | -0.983 |
EBIT 1 | -0.009 | -2.217 | -1.51 | -2.416 | -1.4 | -2.38 | 0.377 | -2.145 |
Operating Margin | -0.09% | -27.92% | -14.57% | -22.75% | -11.22% | -18.14% | 2.85% | -16.02% |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - |
Net income 1 | -1.153 | -2.517 | -1.93 | -2.782 | -3.678 | -2.026 | -0.896 | -1.973 |
Net margin | -11.07% | -31.7% | -18.62% | -26.19% | -29.47% | -15.45% | -6.77% | -14.74% |
EPS 2 | - | -0.0200 | -0.0100 | -0.0200 | -0.0200 | -0.0100 | -0.0100 | -0.0100 |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 2/27/20 | 8/31/20 | 2/25/21 | 8/29/21 | 2/27/22 | 8/30/22 | 2/27/23 | 8/29/23 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 4.12 | 5.7 | 15.4 | 17.6 | 19.4 |
Net Cash position 1 | 2.8 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | -2.091 x | -2.44 x | -4.25 x | -4.235 x | -5.241 x |
Free Cash Flow 1 | -1.29 | -2.55 | 0.28 | -3.8 | -3.46 | 1.43 |
ROE (net income / shareholders' equity) | -12.6% | -30.7% | -59.7% | -194% | -316% | 237% |
ROA (Net income/ Total Assets) | -1.9% | -6.86% | -11.1% | -11.6% | -10.9% | -10.3% |
Assets 1 | 63.38 | 49.71 | 40.14 | 58.53 | 27.98 | 55.59 |
Book Value Per Share 2 | 0.0900 | 0.0700 | 0.0300 | 0.0100 | -0 | -0.0300 |
Cash Flow per Share 2 | 0.0400 | 0.0200 | 0.0100 | 0.0100 | 0.0100 | 0.0100 |
Capex 1 | 0.15 | 0.24 | 0.46 | 0.56 | 0.36 | 0.44 |
Capex / Sales | 0.78% | 1.26% | 2.53% | 2.43% | 1.35% | 1.6% |
Announcement Date | 3/29/19 | 3/31/20 | 3/30/21 | 3/30/22 | 3/29/23 | 3/27/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-22.50% | 8.64M | |
+12.94% | 109B | |
+1.07% | 29.93B | |
+12.31% | 22.41B | |
-11.71% | 18.62B | |
-8.62% | 17.11B | |
+15.31% | 16.27B | |
-5.22% | 12.09B | |
+1.84% | 10.87B | |
-15.91% | 8.57B |
- Stock Market
- Equities
- SBW Stock
- Financials Shekel Brainweigh Ltd.